Your browser doesn't support javascript.
loading
Treatment strategies for and outcomes of older patients with oral squamous cell carcinoma.
Yamada, Shin-Ichi; Kurita, Hiroshi; Nakano, Ryoko; Ohta, Ryosuke; Akita, Daisuke; Hashidume, Masao; Morishita, Kota; Kondo, Eiji; Sakai, Hironori.
Afiliación
  • Yamada SI; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Kurita H; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan. Electronic address: hkurita@shinshu-u.ac.jp.
  • Nakano R; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Ohta R; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Akita D; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Hashidume M; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Morishita K; Department of Clinical Oral Oncology, Unit of Translational Medicine, Course of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kondo E; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Sakai H; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Article en En | MEDLINE | ID: mdl-32102767
OBJECTIVE: The purpose of this study was to investigate factors that have a significant impact on decision making regarding treatment strategies and on the resultant outcomes in older patients with oral squamous cell carcinoma (OSCC). STUDY DESIGN: To define fit, vulnerable, and frail patients, as well as treatment strategies/outcomes, in patients 75 years of age and older with primary OSCC were retrospectively reviewed from the medical records. RESULTS: Among patients with stage I and II tumors, those with a Geriatric 8 (G8) score of 11.5 or greater had favorable outcomes and those with a score less than 11.5 had acceptable outcomes (5-year self-reliance [SR] rates: 80.8 and 53.5%, respectively). Among patients with stage III and IV tumors, those with the Eastern Cooperative Oncology Group-Performance status (ECOG-PS) score less than 2 and/or a G8 score 11.5 or greater mainly received standard therapy, had favorable outcomes (5-year SR rate: 66.7%). The 5-year SR rates of stage IV patients with an ECOG-PS score 2 or greater and those with a G8 score less than 11.5 were poor regardless of any treatment strategy. Although the 5-year SR rate of patients with standard therapy was 73.4%, that of patients receiving other curative therapies was 0%. CONCLUSIONS: In patients with stage III/IV, ECOG-PS 2 or greater, and/or G8 score less than 11.5, treatment was difficult, and the prognosis was poor.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas Tipo de estudio: Observational_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Oral Surg Oral Med Oral Pathol Oral Radiol Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas Tipo de estudio: Observational_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Oral Surg Oral Med Oral Pathol Oral Radiol Año: 2020 Tipo del documento: Article País de afiliación: Japón
...